These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
508 related items for PubMed ID: 12154400
1. DNA methylation and gene silencing in cancer: which is the guilty party? Clark SJ, Melki J. Oncogene; 2002 Aug 12; 21(35):5380-7. PubMed ID: 12154400 [Abstract] [Full Text] [Related]
2. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells. Stirzaker C, Song JZ, Davidson B, Clark SJ. Cancer Res; 2004 Jun 01; 64(11):3871-7. PubMed ID: 15172996 [Abstract] [Full Text] [Related]
3. Dormant hypermethylated tumour suppressor genes: questions and answers. Esteller M. J Pathol; 2005 Jan 01; 205(2):172-80. PubMed ID: 15643671 [Abstract] [Full Text] [Related]
4. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning. Hinshelwood RA, Melki JR, Huschtscha LI, Paul C, Song JZ, Stirzaker C, Reddel RR, Clark SJ. Hum Mol Genet; 2009 Aug 15; 18(16):3098-109. PubMed ID: 19477956 [Abstract] [Full Text] [Related]
5. Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells. Song JZ, Stirzaker C, Harrison J, Melki JR, Clark SJ. Oncogene; 2002 Feb 07; 21(7):1048-61. PubMed ID: 11850822 [Abstract] [Full Text] [Related]
7. DNA methylation and cancer. Jones PA. Oncogene; 2002 Aug 12; 21(35):5358-60. PubMed ID: 12154398 [Abstract] [Full Text] [Related]
8. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Esteller M. Oncogene; 2002 Aug 12; 21(35):5427-40. PubMed ID: 12154405 [Abstract] [Full Text] [Related]
10. Gene silencing by DNA methylation in haematological malignancies. Boultwood J, Wainscoat JS. Br J Haematol; 2007 Jul 12; 138(1):3-11. PubMed ID: 17489980 [Abstract] [Full Text] [Related]
11. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. Esteller M, Herman JG. J Pathol; 2002 Jan 12; 196(1):1-7. PubMed ID: 11748635 [Abstract] [Full Text] [Related]
12. The role of DNA hypermethylation in human neoplasia. Toyota M, Issa JP. Electrophoresis; 2000 Jan 12; 21(2):329-33. PubMed ID: 10675010 [Abstract] [Full Text] [Related]
13. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer. Yan PS, Shi H, Rahmatpanah F, Hsiau TH, Hsiau AH, Leu YW, Liu JC, Huang TH. Cancer Res; 2003 Oct 01; 63(19):6178-86. PubMed ID: 14559801 [Abstract] [Full Text] [Related]
15. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Robert MF, Morin S, Beaulieu N, Gauthier F, Chute IC, Barsalou A, MacLeod AR. Nat Genet; 2003 Jan 01; 33(1):61-5. PubMed ID: 12496760 [Abstract] [Full Text] [Related]
18. DNA methylation in cancer: too much, but also too little. Ehrlich M. Oncogene; 2002 Aug 12; 21(35):5400-13. PubMed ID: 12154403 [Abstract] [Full Text] [Related]
19. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer. Karpinski P, Ramsey D, Grzebieniak Z, Sasiadek MM, Blin N. Mol Cancer Res; 2008 Apr 12; 6(4):585-91. PubMed ID: 18403637 [Abstract] [Full Text] [Related]